File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0165-4608(98)00184-8
- Scopus: eid_2-s2.0-0032897329
- PMID: 10198617
- WOS: WOS:000079485600004
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: BCR/ABL translocation in adult acute lymphoblastic leukemia: A comparison of conventional and interphase cytogenetic studies
Title | BCR/ABL translocation in adult acute lymphoblastic leukemia: A comparison of conventional and interphase cytogenetic studies |
---|---|
Authors | |
Issue Date | 1999 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/cancergene |
Citation | Cancer Genetics And Cytogenetics, 1999, v. 110 n. 1, p. 19-22 How to Cite? |
Abstract | Twenty-four adult Chinese patients with do nova acute lymphoblastic leukemia (ALL) were studied for the BCR/ABL translocation using both conventional cytogenetics and fluorescence in situ hybridization (FISH). Eight (33%) patients had the translocation as shown by FISH and all were B- lineage ALL (8/19, 42%). Conventional cytogenetics revealed a t(9;22)(q34;q11) in six of them, but was either unsuccessful or not done in the other two. Seven of the eight positive cases (88%) showed a breakpoint at the minor breakpoint cluster region (m-BCR), which was confirmed by reverse transcriptase polymerase chain reaction (RT-PCR). To conclude, the frequency of BCR/ABL translocation in Chinese patients with de nova ALL is comparable to patients in the Western hemisphere, in contrast to a previous report. The predominance of m-BCR/ABL fusion among these Chinese patients with BCR/ABL translocation is also similar to patients in the Western population. Fluorescence in situ hybridization is a sensitive, specific and relatively simple technique for demonstrating this important unfavorable prognostic marker in ALL, even in a routine service laboratory setting. |
Persistent Identifier | http://hdl.handle.net/10722/148155 |
ISSN | 2012 Impact Factor: 1.929 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | So, CC | en_HK |
dc.contributor.author | Wong, KF | en_HK |
dc.contributor.author | Chung, J | en_HK |
dc.contributor.author | Kwong, YL | en_HK |
dc.date.accessioned | 2012-05-29T06:11:09Z | - |
dc.date.available | 2012-05-29T06:11:09Z | - |
dc.date.issued | 1999 | en_HK |
dc.identifier.citation | Cancer Genetics And Cytogenetics, 1999, v. 110 n. 1, p. 19-22 | en_HK |
dc.identifier.issn | 0165-4608 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/148155 | - |
dc.description.abstract | Twenty-four adult Chinese patients with do nova acute lymphoblastic leukemia (ALL) were studied for the BCR/ABL translocation using both conventional cytogenetics and fluorescence in situ hybridization (FISH). Eight (33%) patients had the translocation as shown by FISH and all were B- lineage ALL (8/19, 42%). Conventional cytogenetics revealed a t(9;22)(q34;q11) in six of them, but was either unsuccessful or not done in the other two. Seven of the eight positive cases (88%) showed a breakpoint at the minor breakpoint cluster region (m-BCR), which was confirmed by reverse transcriptase polymerase chain reaction (RT-PCR). To conclude, the frequency of BCR/ABL translocation in Chinese patients with de nova ALL is comparable to patients in the Western hemisphere, in contrast to a previous report. The predominance of m-BCR/ABL fusion among these Chinese patients with BCR/ABL translocation is also similar to patients in the Western population. Fluorescence in situ hybridization is a sensitive, specific and relatively simple technique for demonstrating this important unfavorable prognostic marker in ALL, even in a routine service laboratory setting. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/cancergene | en_HK |
dc.relation.ispartof | Cancer Genetics and Cytogenetics | en_HK |
dc.rights | Cancer Genetics and Cytogenetics. Copyright © Elsevier Inc. | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fusion Proteins, Bcr-Abl - Genetics | en_US |
dc.subject.mesh | Genes, Abl | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interphase | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Oncogene Proteins - Genetics | en_US |
dc.subject.mesh | Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics | en_US |
dc.subject.mesh | Protein-Tyrosine Kinases | en_US |
dc.subject.mesh | Proto-Oncogene Proteins | en_US |
dc.subject.mesh | Proto-Oncogene Proteins C-Bcr | en_US |
dc.subject.mesh | Translocation, Genetic | en_US |
dc.title | BCR/ABL translocation in adult acute lymphoblastic leukemia: A comparison of conventional and interphase cytogenetic studies | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | So, CC:scc@pathology.hku.hk | en_HK |
dc.identifier.email | Kwong, YL:ylkwong@hku.hk | en_HK |
dc.identifier.authority | So, CC=rp00391 | en_HK |
dc.identifier.authority | Kwong, YL=rp00358 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0165-4608(98)00184-8 | en_HK |
dc.identifier.pmid | 10198617 | - |
dc.identifier.scopus | eid_2-s2.0-0032897329 | en_HK |
dc.identifier.hkuros | 41971 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0032897329&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 110 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 19 | en_HK |
dc.identifier.epage | 22 | en_HK |
dc.identifier.isi | WOS:000079485600004 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | So, CC=7102919978 | en_HK |
dc.identifier.scopusauthorid | Wong, KF=7404759860 | en_HK |
dc.identifier.scopusauthorid | Chung, J=8834575100 | en_HK |
dc.identifier.scopusauthorid | Kwong, YL=7102818954 | en_HK |
dc.identifier.issnl | 0165-4608 | - |